long intergenic non-protein coding RNA 2836Genealiases: []
Q-omics provides the consensus-scored LINC02836 profile across patient tissues and cancer cell-line models. LINC02836 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, LINC02836 is differentially expressed in 7, with the highest sampling consensus in KIRC. Additionally, LINC02836 RNA expression shows 9,608 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight SKCM, KIRC, and GBM as cancer lineages where LINC02836 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02836 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02836 survival associations across molecular data types. LINC02836 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02836 RNA expression–survival associations across cancer types. High LINC02836 expression shows unfavorable associations in UVM, UCS, READ and KIRP, but favorable associations in SKCM and CESC. The SKCM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for LINC02836 RNA expression.
This table summarizes LINC02836 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02836. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02836 shows higher tumor expression in KIRC, LUSC, PRAD, LUAD, COAD and HNSC. The KIRC box plot shows higher LINC02836 RNA expression in tumor versus normal tissue (log2 FC = +0.076, t-test p < 0.001).
This table shows molecular features associated with LINC02836 in patient tissues and cancer cell lines. In patient samples, LINC02836 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
